A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

NCT01830920 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

452

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DRUG: THR-184
DRUG: Placebo

Sponsor

Thrasos Innovation, Inc.